Modalis Therapeutics Corporation (TYO:4883)
Japan · Delayed Price · Currency is JPY 34.00
+1.00 (3.03%)
Jul 21, 2026, 1:16 PM JST
Modalis Therapeutics Market Cap
Modalis Therapeutics has a market cap or net worth of 3.18 billion as of July 20, 2026. Its market cap has decreased by -53.04% in one year.
Market Cap
3.18B
Enterprise Value
366.79M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
34.00
ChartMarket Cap Chart
Since August 3, 2020, Modalis Therapeutics's market cap has decreased from 60.66B to 3.18B, a decrease of -94.76%. That is a compound annual growth rate of -39.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 3.18B | -32.36% |
| Dec 30, 2025 | 4.70B | -33.61% |
| Dec 30, 2024 | 7.08B | 80.79% |
| Dec 29, 2023 | 3.92B | -59.92% |
| Dec 30, 2022 | 9.77B | -44.97% |
| Dec 30, 2021 | 17.75B | -71.83% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mizuho Medy | 31.66B |
| Fuso Pharmaceutical Industries,Ltd. | 18.73B |
| Pharma Foods International | 17.08B |
| Taiko Pharmaceutical | 13.97B |
| Wakamoto Pharmaceutical | 9.64B |
| Morishita Jintan | 8.95B |
| Solasia Pharma K.K. | 7.10B |
| WDB coco | 6.20B |